Suraksha Diagnostic Limited — Board Meeting, 08-08-2025: Outcome of Board Meeting

Suraksha Diagnostic's board has approved the consolidated financial results for the quarter ended June 30, 2025. The company reported robust revenue from operations of ₹72.59 Cr, a significant jump from ₹60.73 Cr in the same quarter last year. Profit for the period also increased, reaching ₹9.18 Cr compared to ₹7.67 Cr previously. This strong performance follows the recent strategic move of making Fetomat Wellness Private Limited a subsidiary, with the acquisition of an additional 46.83% stake completed on April 9, 2025. This integration should further bolster future growth.